Skip to main content
. 2018 Sep 4;5(1):e000289. doi: 10.1136/bmjresp-2018-000289

Figure 2.

Figure 2

Patient case study 1—chronic fibrosing ILD in the setting of IPAF. CCP, cyclic citrullinated peptide; DLco, diffusing capacity of the lung for carbon monoxide; FVC, forced vital capacity; HRCT, high-resolution CT; IIP, interstitial pneumonia; ILD, interstitial lung disease; IPAF, interstitial pneumonia with autoimmune features; MDT, multidisciplinary team; UIP, usual interstitial pneumonia.